AVALON Pharma
Moazam A. Shah, FCA, MAICD, has extensive experience in finance and leadership roles across various industries. Currently serving as Chief Financial Officer at AVALON Pharma since September 2024, Moazam previously held the same position at Aspen Medical from August 2019 to September 2024, contributing to global healthcare solutions. Additional roles include Chair of the Finance, Audit & Risk Committee at Aspen Medical - UAE, Chair of the Corporate Advisory Panel and Regional Councillor at Chartered Accountants Australia and New Zealand, and board positions with Health Care Fiji and TESSA Inc. Moazam has a strong background in financial management, including significant achievements in increasing working capital, leading merger and acquisition efforts, and implementing ERP systems across multiple organizations. Moazam's qualifications include memberships and fellowships with various accounting bodies, underscoring expertise in the field.
This person is not in the org chart
This person is not in any teams
AVALON Pharma
Avalon Pharma manufactures topical preparations such as creams, lotions, other topical solutions, and cosmetic products. It produces disinfectants, sanitizers, mouthwashes, and a volume of hygiene products. They focus on developing products and formulations that will meet the needs and expectations of customers.